Alternate Care Pharmaceutical Distributor | Morris & Dickson

Supporting Pharmacies Where They Support Patients.

Morris & Dickson supports the growing shift to alternate sites of care—delivering the products, access, and expertise needed beyond the traditional care settings. From community-based long term care to institutions, we help providers expand services while maintaining efficiency, compliance, and high-quality patient outcomes.

A full range of pharmaceutical products

Everything your alternate care pharmacy needs is under one roof at M&D. Morris & Dickson offers over 30,000 pharmaceutical and healthcare SKUs. Pharmacies can rely on M&D for quick responses, straightforward business practices, and service that goes above and beyond.

Our expansive pharmaceutical distribution for alternate care pharmacies includes:

Brand
Generics
Specialty
Vaccines
OTC
Home Health
Plasma
Biosimilars

Advanced services for alternate care

Morris & Dickson’s pharmacy roots date back to 1841. That’s why M&D can help alternate care pharmacies or clinics positively impact the bottom line and improve patient care through additional business services that leverage our management, logistical, and technological expertise.

Clinics

High fill rates, consistent product availability, and transparent pricing models allow clinics to focus on patient care—supported by access to specialty therapies and cost containment programs through BeaconMD.

Correctional Facilities

Inventory management and replenishment solutions that drive cost reduction and operational efficiency.

State Agencies

Advanced purchasing tools, experienced support, and excellent distribution service.

FQHCs

Serving the unique distribution needs of federally qualified pharmacies.

Long-Term Care Pharmacies

Distribution services and support as well as software solutions for better nursing home management.

Infusion Pharmacies

Reliable access to specialty and complex therapies, combined with the ability to manage multiple GPO contract portfolios—enhanced by BeaconMD for cost optimization and ProdigyMD for access to plasma-derived and hard-to-source products.

This is an exciting, transformational time for our 180-year-old company. We look forward to developing a new and better model for the healthcare supply chain.

Jody Hatcher, CEO — Morris & Dickson

IN THE NEWS

Alternate care and pharmaceutical industry news from Morris & Dickson.

May 19, 2026

Chronic Pain Management in 2026: A Practical Guide for Pharmacists Navigating Safety, Compliance, and Patient Care

Read More
May 5, 2026

Cholesterol Management in 2026: What’s Changed and What Pharmacists Need to Do Now

Read More
April 2, 2026

Loargys® (pegzilarginase-nbln) now available to patients in the U.S. just 5 weeks after FDA approval

Read More
More News